- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02301663
Development of a Novel Stress Testing Protocol to Define the Relationship Between Coronary Microvascular Dysfunction and Diastology in Women With Angina But No Evidence of Obstructive Coronary Artery Disease
August 31, 2023 updated by: Noel Bairey Merz, Cedars-Sinai Medical Center
DEVELOPMENT OF A NOVEL STRESS TESTING PROTOCOL TO DEFINE THE RELATIONSHIP BETWEEN CORONARY MICROVASCULAR DYSFUNCTION AND DIASTOLOGY IN WOMEN WITH ANGINA BUT NO EVIDENCE OF OBSTRUCTIVE CORONARY ARTERY DISEASE
Microvascular coronary dysfunction (MCD) (abnormities in small blood vessels/arteries in heart) with symptoms of persistent chest pain, primarily impacts women.
There are an estimated 2-3 million women in the US with MCD and about 100,000 new cases annually.
Recent data from our research group suggests that coronary microvascular disease impairs the way the heart relaxes.
This pilot study will attempt to exacerbate this phenotype in an effort to better understand the pathophysiology of the disease.
The investigators will recruit 30 volunteers total (10 healthy calibration subjects, 10 women with microvascular disease, and 10 age-match women for the group with microvascular disease).
Subjects will undergo a series of "stress" maneuvers in conjunction with advanced cardiac magnetic resonance imaging.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Barbra Streisand Women's Heart Center
- Phone Number: 310-423-9666
Study Locations
-
-
California
-
Los Angeles, California, United States, 90048
- Recruiting
- Cedars-Sinai Medical Center
-
Contact:
- Nicole Tovar
- Phone Number: 310-248-6960
- Email: nicole.tovar@cshs.org
-
Contact:
- BS WHC, MS
- Phone Number: 310-423-9666
- Email: bswhc.research@cshs.org
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Fully understanding and willing to undergo study procedures
- Male or Female greater than or equal to 18 years of age
- Understanding and willing to sign consent form.
Exclusion Criteria:
- History of cardiovascular, pulmonary, or neurological disease
- Hypertension (sitting blood pressure >140/90 mmHg, with measurements recorded on at least 2 occasions)
- Diabetes
- Unable to give informed consent;
- Contra-indication to CMRI testing, including claustrophobia and metallic implants
- Adherence or retention issues;
- Women who are pregnant.
- Allergy to animal dander.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Women w/microvascular disease
10 women with microvascular disease
|
Subjects will be asked to squeeze and handgrip dynamometer to increase cardiac metabolic demand
Subjects will breathe a lower concentration of oxygen to simulate the effects of altitude.
Subjects will perform leg exercise to increase metabolic demand.
|
|
Experimental: Normal controls
10 age-matched women with no evidence of microvascular disease
|
Subjects will be asked to squeeze and handgrip dynamometer to increase cardiac metabolic demand
Subjects will breathe a lower concentration of oxygen to simulate the effects of altitude.
Subjects will perform leg exercise to increase metabolic demand.
|
|
Experimental: calibration
10 healthy individuals who will help to synchronize our imaging and stress testing maneuvers.
|
Subjects will be asked to squeeze and handgrip dynamometer to increase cardiac metabolic demand
Subjects will breathe a lower concentration of oxygen to simulate the effects of altitude.
Subjects will perform leg exercise to increase metabolic demand.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Diastolic function by MRI
Time Frame: 24 hours
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michael Nelson, PhD, Cedars-Sinai Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2014
Primary Completion (Estimated)
December 1, 2030
Study Completion (Estimated)
December 1, 2030
Study Registration Dates
First Submitted
November 22, 2014
First Submitted That Met QC Criteria
November 25, 2014
First Posted (Estimated)
November 26, 2014
Study Record Updates
Last Update Posted (Actual)
September 1, 2023
Last Update Submitted That Met QC Criteria
August 31, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Diastolic stress testing
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Microvascular Coronary Dysfunction
-
Peking University First HospitalRecruitingCoronary Microvascular DysfunctionChina
-
Amir LermanCompletedCoronary Microvascular DysfunctionUnited States
-
Ge JunboRainMed MedicalCompleted
-
Mette ZanderHvidovre University HospitalCompletedCoronary Microvascular DysfunctionDenmark
-
Cedars-Sinai Medical CenterActive, not recruitingMicrovascular Coronary DysfunctionUnited States
-
King's College LondonGuy's and St Thomas' NHS Foundation TrustNot yet recruitingCoronary Microvascular Dysfunction (CMD)
-
Peking University Third HospitalNot yet recruitingCoronary Microvascular Dysfunction (CMD)China
-
Royal United Hospitals Bath NHS Foundation TrustNational Institute for Health Research, United KingdomRecruitingMicrovascular Angina | Coronary Microvascular Dysfunction (CMD) | Microvascular Coronary DysfunctionUnited Kingdom
-
Cedars-Sinai Medical CenterWithdrawnMicrovascular Coronary DysfunctionUnited States
-
Medstar Health Research InstituteRecruiting
Clinical Trials on Handgrip
-
University of CalgaryRecruiting
-
Thammasat UniversityCompletedChronic Obstructive Pulmonary DiseaseThailand
-
University of Texas at AustinCompleted
-
Florida State UniversityRecruiting
-
TriHealth Inc.Enrolling by invitationDeep Vein ThrombosisUnited States
-
Centre Hospitalier Régional d'OrléansCompletedEffect of Vibratory Tendon Stimulation on Muscle Fatigue in the Acute Post-stroke Phase (VIBRAMAIN1)Stroke | Fatigue | Stroke, AcuteFrance
-
University of SouthamptonUniversity Hospital Southampton NHS Foundation TrustUnknownInflammatory Bowel Disease | Nutrition
-
Hospices Civils de LyonCompleted
-
University Health Network, TorontoUnknown
-
Riphah International UniversityCompletedSports Physical TherapyPakistan